n-(3-(aminomethyl)benzyl)acetamidine has been researched along with melatonin in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gundogdu, G; Guven, A; Kesik, V; Korkmaz, A; Oztas, E; Tunc, T; Uysal, B; Vurucu, S | 1 |
| Akgul, EO; Cayci, T; Cetiner, S; Ersoz, N; Guven, A; Korkmaz, A; Oztas, E; Turk, E; Uysal, B | 1 |
| Acikel, C; Arpaci, F; Ataergin, S; Demirbas, S; Ersoz, N; Korkmaz, A; Kurt, B; Kurt, YG; Kuzhan, O; Oter, S; Ozet, A; Ozler, M; Oztas, Y; Ozturk, B; Ozturk, M; Topal, T; Uysal, B; Yasar, M | 1 |
3 other study(ies) available for n-(3-(aminomethyl)benzyl)acetamidine and melatonin
| Article | Year |
|---|---|
Melatonin and 1400 W ameliorate both intestinal and remote organ injury following mesenteric ischemia/reperfusion.
Topics: Amidines; Animals; Antioxidants; Benzylamines; Enzyme Inhibitors; Glutathione Peroxidase; Glutathione Peroxidase GPX1; Intestinal Mucosa; Intestines; Kidney; Liver; Lung; Male; Malondialdehyde; Melatonin; Mesenteric Vascular Occlusion; Nitric Oxide Synthase Type II; Oxidative Stress; Rats; Rats, Wistar; Reperfusion Injury; Superoxide Dismutase; Survival Rate; Tyrosine | 2009 |
Comparison of the efficacy of melatonin and 1400W on renal ischemia/reperfusion injury: a role for inhibiting iNOS.
Topics: Amidines; Animals; Antioxidants; Benzylamines; Disease Models, Animal; Enzyme Inhibitors; Kidney; Kidney Diseases; Male; Melatonin; Nitric Oxide Synthase; Rats; Rats, Sprague-Dawley; Reperfusion Injury | 2009 |
Efficacy of melatonin, mercaptoethylguanidine and 1400W in doxorubicin- and trastuzumab-induced cardiotoxicity.
Topics: Amidines; Animals; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Benzylamines; Creatine Kinase; Doxorubicin; Glutathione Peroxidase; Guanidines; Heart; Male; Malondialdehyde; Melatonin; Rats; Rats, Sprague-Dawley; Superoxide Dismutase; Trastuzumab | 2011 |